Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target.
- DOI
- 10.1038/s41401-026-01954-y
- Published
- 2026 Nov 10
- Container
- Acta pharmacologica Sinica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41401-026-01954-y,
title = {Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target.},
author = {Mayamba BS and Chaurembo AI and Chanda F and Zheng X and Liang YT and Deng WH and Liu Y and Huang ZF and Lin YF and Xing N and Liu PP and Lin HB},
year = {2026},
journal = {Acta pharmacologica Sinica},
doi = {10.1038/s41401-026-01954-y},
url = {https://doi.org/10.1038/s41401-026-01954-y}
}RIS
TY - JOUR TI - Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target. AU - Mayamba BS AU - Chaurembo AI AU - Chanda F AU - Zheng X AU - Liang YT AU - Deng WH AU - Liu Y AU - Huang ZF AU - Lin YF AU - Xing N AU - Liu PP AU - Lin HB PY - 2026 JO - Acta pharmacologica Sinica DO - 10.1038/s41401-026-01954-y UR - https://doi.org/10.1038/s41401-026-01954-y ER -
APA
BS, M., AI, C., F, C., X, Z., YT, L., WH, D., Y, L., ZF, H., YF, L., N, X., PP, L., & HB, L. (2026). Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target.. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01954-y
Source records
- pubmed · retrieved 2026-11-10T20:35:07.241Z